You have 9 free searches left this month | to do more
Showing 1 - 21 of
21 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Active, not recruiting
  • Hematologic Maligmancy
  • Inotuzumab ozogamicin
  • Seoul, Korea, Republic of
    Pfizer
2021-11-22
Nov 22, 2021
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Inotuzumab ozogamicin
  • +6 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2021-06-16
Jun 16, 2021
D
Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-10-19
Oct 19, 2021
M
Terminated
  • CD22 Positive
  • +2 more
  • Inotuzumab Ozogamicin
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-17
Mar 17, 2021
M
Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab Ozogamicin
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-04
Mar 4, 2021
N
Withdrawn
  • Acute Lymphoblastic Leukemia
  • Tisagenlecleucel
  • +2 more
  • (no location specified)
2020-07-07
Jul 7, 2020
U
Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
2021-05-12
May 12, 2021
U
Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Inotuzumab ozogamicin
  • +6 more
  • Charlottesville, Virginia
  • +1 more
2022-01-04
Jan 4, 2022
R
Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • +7 more
  • Inotuzumab Ozogamicin
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-10-28
Oct 28, 2021
U
Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-11-15
Nov 15, 2021
M
Recruiting
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-06-25
Jun 25, 2020
P
Recruiting
  • Leukemia
  • +2 more
  • inotuzumab ozogamicin-dose level 2
  • Inotuzumab ozogamicin-dose level 1
  • Los Angeles, California
  • +49 more
2022-01-04
Jan 4, 2022
M
Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-07
May 7, 2021
M
Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Allogeneic Bone Marrow Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-02-25
Feb 25, 2020
M
Recruiting
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +2 more
  • Blinatumomab
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-04-29
Apr 29, 2021
M
Terminated
  • Acute Lymphoblastic Leukemia in Remission
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-18
Mar 18, 2021
M
Recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • Blinatumomab
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-02-21
Feb 21, 2021
C
Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Birmingham, Alabama
  • +141 more
2021-10-15
Oct 15, 2021
N
Recruiting
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • Inotuzumab Ozogamicin
  • Birmingham, Alabama
  • +260 more
2022-01-04
Jan 4, 2022
C
Recruiting
  • B Acute Lymphoblastic Leukemia
  • +4 more
  • Calaspargase Pegol-mknl
  • +15 more
  • Birmingham, Alabama
  • +212 more
2021-09-02
Sep 2, 2021
M
Recruiting
  • Leukemia, Acute Lymphoblastic
  • Omitted Doxorubicin
  • +5 more
  • Brussels, Belgium
  • +100 more
2021-01-04
Jan 4, 2021